HIV diversity study in Cameroon
Part of Immune system & allergy, Infections clinical trials.
This study looks at rare types of HIV-1 (non-group M) in Cameroon. It uses stored blood samples and new tests to learn more about these strains, which may help improve treatment and understanding of the virus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were part of a national health survey in Cameroon in 2011 or 2018 and tested positive for HIV
- You came to Centre Pasteur in Yaoundé or Garoua for HIV testing or viral load monitoring
- You are 21 years old or older
- Your infection is not the common type of HIV-1 (Group M)
- You have enough dried blood spot sample available
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at HIV resistance and virus types in people who were just diagnosed with HIV and have not yet taken antiretroviral medications (except PrEP or PEP). It aims to better understand resistance patterns and track how HIV spreads.
This study tests a mobile team approach to screen for cervical cancer using HPV testing in women living with HIV. It aims to make screening easier to access and more effective.
This study follows people with a very recent HIV infection and collects blood and other samples to learn more about the infection soon after it starts. It may help researchers better understand early HIV and improve future treatments.
This study looks at how the immune system and HIV behave in people on long-term HIV treatment (ART), using blood samples that will be stored for future tests for up to 20 years. It may help researchers understand how well treatment is controlling HIV and improve future care.
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
This study looks at the sexual health of women from sub-Saharan Africa who were recently diagnosed with HIV in France. It aims to understand missed opportunities for prevention and improve care.
Hear when a new HIV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.